ST
Sarina Tanimoto
Chief Medical Officer

Sarina Tanimoto insider trades: ARS Pharmaceuticals (SPRY) stock sales

Chief Medical Officer, ARS Pharmaceuticals Last trade Aug 20, 2025 31 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
49
Open-market trades
since 2024
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sarina reports to the SEC

Open-market buys and sales

49 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 20, 2025SPRY↓ Sell10b5-1$704K
Dec 17, 2024SPRY↓ Sell10b5-1$584K
Dec 17, 2024SPRY↓ Sell10b5-1$584K
Dec 10, 2024SPRY↓ Sell10b5-1$658K
Dec 10, 2024SPRY↓ Sell10b5-1$658K
Nov 19, 2024SPRY↓ Sell10b5-1$698K
Nov 19, 2024SPRY↓ Sell10b5-1$697K
Nov 12, 2024SPRY↓ Sell10b5-1$842K
Nov 12, 2024SPRY↓ Sell10b5-1$755K
Nov 12, 2024SPRY↓ Sell10b5-1$87K
Oct 15, 2024SPRY↓ Sell10b5-1$744K
Oct 15, 2024SPRY↓ Sell10b5-1$744K
Oct 8, 2024SPRY↓ Sell10b5-1$691K
Oct 8, 2024SPRY↓ Sell10b5-1$691K
Sep 17, 2024SPRY↓ Sell10b5-1$647K
Sep 17, 2024SPRY↓ Sell10b5-1$647K
Sep 10, 2024SPRY↓ Sell10b5-1$575K
Sep 10, 2024SPRY↓ Sell10b5-1$575K
Aug 20, 2024SPRY↓ Sell10b5-1$751K
Aug 20, 2024SPRY↓ Sell10b5-1$751K
Aug 13, 2024SPRY↓ Sell10b5-1$624K
Aug 13, 2024SPRY↓ Sell10b5-1$452K
Aug 13, 2024SPRY↓ Sell10b5-1$172K
Jul 16, 2024SPRY↓ Sell10b5-1$570K
Jul 16, 2024SPRY↓ Sell10b5-1$570K
Jul 9, 2024SPRY↓ Sell10b5-1$481K
Jul 9, 2024SPRY↓ Sell10b5-1$481K
Jun 12, 2024SPRY↓ Sell10b5-1$457K
Jun 12, 2024SPRY↓ Sell10b5-1$457K
May 16, 2024SPRY↓ Sell10b5-1$453K
May 16, 2024SPRY↓ Sell10b5-1$453K
May 7, 2024SPRY↓ Sell10b5-1$467K
May 7, 2024SPRY↓ Sell10b5-1$467K
Apr 16, 2024SPRY↓ Sell10b5-1$464K
Apr 16, 2024SPRY↓ Sell10b5-1$464K
Apr 9, 2024SPRY↓ Sell10b5-1$464K
Apr 9, 2024SPRY↓ Sell10b5-1$464K
Mar 25, 2024SPRY↓ Sell10b5-1$447K
Mar 25, 2024SPRY↓ Sell10b5-1$444K
Mar 21, 2024SPRY↓ Sell10b5-1$12K
Mar 21, 2024SPRY↓ Sell10b5-1$9K
Mar 15, 2024SPRY↓ Sell10b5-1$457K
Mar 15, 2024SPRY↓ Sell10b5-1$457K
Feb 29, 2024SPRY↓ Sell10b5-1$18K
Feb 29, 2024SPRY↓ Sell10b5-1$9K
Feb 29, 2024SPRY↓ Sell10b5-1$7K
Feb 28, 2024SPRY↓ Sell10b5-1$447K
Feb 28, 2024SPRY↓ Sell10b5-1$231K
Feb 28, 2024SPRY↓ Sell10b5-1$220K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SPRY insiders

Open-market trades in the last 12 months

About Sarina Tanimoto's insider trades

Sarina Tanimoto is Chief Medical Officer at ARS Pharmaceuticals (SPRY). Since Feb 28, 2024, Sarina has reported no open-market purchases and 49 sales worth $23.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

49 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (5 filings), option exercises (3 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SPRY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.